Detalhe da pesquisa
1.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
Cell
; 173(6): 1439-1453.e19, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856956
2.
FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.
Eur J Immunol
; 43(11): 2980-92, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23857366
3.
Cutting edge: FcR-like 6 is an MHC class II receptor.
J Immunol
; 185(1): 23-7, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519654
4.
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.
JCI Insight
; 3(24)2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568030
5.
Fc receptor-like proteins (FCRL): immunomodulators of B cell function.
Adv Exp Med Biol
; 596: 155-62, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17338184
6.
FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia.
Eur J Immunol
; 38(11): 3159-66, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18991291